medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2014, Number 1

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2014; 30 (1)

Reasons for a cord blood bank at the Institute of Hematology and Immunology, Cuba

Rivero JRA

Language: Spanish
References: 15
Page: 4-10
PDF size: 42.97 Kb.


ABSTRACT

During the last 45 years, alogenic stem cell transplant has been an every day most used form of treatment for the cure of malignant hemopathies and other genetic disorders such as sickle cell disease and some primary immunodeficiencies. Nevertheless, the lack of adequate donors caused by not having the patients possible histocompatible relatives has made it necessary to look for alternatives in "non related" donors to guarantee the efficacy and security of the transplant. A commonly used source is cord blood (CB); the first transplant was made in 1989 and in the last 25 years it has been widely applied in developed countries. CB banks have become an important reserve for these treatments and for regenerative cell therapy, due to their multiple advantages. Having a public CB bank in Cuba is a need for the development of our National Health System which will allow us to join our efforts with the international scientific community in the struggle for a better health care for our people and other countries of the world, particularly Latin America.


REFERENCES

  1. Smith AR, Wagner JE. Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood. Br J Haematol. 2009 Oct;147(2):246-61.

  2. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989 Oct;321 (17):1174-8.

  3. Ballen KK, Spitzer TR. The great debate: haploidentical or cord blood transplant. Bone Marrow Transplant. 2011 Mar;46(3):323-9.

  4. Kurtzberg J, Graham M, Casey J, Olson J, Stevens C, Rubinstein P. The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. Blood Cells. 1994;20(2-3):275-83.

  5. Wagner J, Rosenthal J, Sweetman R, Shu X, Davies S, Ramsay N, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood. 1996 Aug;88(3):795-802.

  6. Gluckman E. Ten years of cord blood transplantation: from bench to bedside. Br J Haematol. 2009 Oct;147(2):192-9.

  7. OPS. Legislación sobre donación y trasplante de órganos, tejidos y células: compilación y análisis comparado. Washington DC: OPS. 2013. (Accedido en 15/7/2013). Disponible en: http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=21392&Itemid

  8. OMS. Principios Rectores de la OMS sobre Trasplante de Células, Tejidos y Órganos Humanos. Aprobados por la 63.ª Asamblea Mundial de la Salud, de mayo de 2010, en su resolución WHA63.22. (Accedido en 15/7/2013). Disponible en: http://www.who.int/transplantation/GuidingPrinciplesTransplantation_WHA63.22sp.pdf

  9. Bone Marrow Donors Worldwide. BMDW-Bone Marrow Donors Worldwide. The Netherlands. (Accedido en 15/7/2013). Disponible en http://www.bmdw.org

  10. National Cord Blood Program. List of diseases treated with NCBP units. New York Blood Center. (Accedido en 14-7-2013). Disponible en: http://www.nationalcordbloodprogram.org /patients/ncbp_diseases.pdf

  11. Barker IN, Byam CE, Kernan NA, Lee SL, Hawke RM, Doshi KA, et al. Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities. Biol Blood Marrow Transplant. 2010 Nov;16(11):1541-8.

  12. Querol S, Rubinstein P, Marsh SEG, Goldman J, Madrigal JA. Cord blood banking: providing cord blood banking for a nation. Br J Haematol. 2009 Oct;147(2):227-35.

  13. Ballen KK, Koreth J, Chen YB, Dey BR, Spitzer TR. Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant. Blood. 2012 Mar 1;119(9):1972-80.

  14. Cohen YC, Scaradavou A, Stevens CE, Rubinstein P, Gluckman E, Rocha V, et al. Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. Bone Marrow Transplant. 2011 Jan;46(1):70-6.

  15. Petz LD, Redei I, Bryson Y, Regan D, Kurtzberg J, Shpall E, et al. Hematopoietic cell transplantation with cord blood for cure of HIV infections. Biol Blood Marrow Transplant. 2013 Mar;19(3):393-7.




2020     |     www.medigraphic.com